Navigation Links
The International Society for Stem Cell Research Releases New Guidelines to Shape Future of Stem Cell Therapy
Date:12/3/2008

DEERFIELD, Ill., Dec. 3 /PRNewswire/ -- Today, the International Society for Stem Cell Research (ISSCR), the world's leading professional organization of stem cell researchers, released new guidelines for the responsible development of safe and effective stem cell therapies for patients. A Commentary article that summarizes the Guidelines for the Clinical Translation of Stem Cells will be published by Cell Press in the December issue of Cell Stem Cell, the official affiliated journal of the ISSCR.

These guidelines define a roadmap for medical researchers and doctors, outlining what needs to be accomplished to move stem cells from promising research to proven treatments for patients. The new guidelines will accelerate the translation of stem cell research into practice while addressing associated scientific, clinical, regulatory, ethical and social issues. Founded on core principles of scientific rigor and ethical conduct, the recommendations offered in the guidelines include an insistence on expert evaluation and independent oversight, a thorough informed consent process to provide patients with essential information on the unique aspects of stem cell-based treatments, and transparency in reporting of clinical trial results.

"Our guidelines will arm patients and their doctors with the information they need to make decisions about whether to seek stem cell treatments," said Dr. Olle Lindvall, co-chair of the ISSCR task force that developed the guidelines and professor in clinical neurology at the University of Lund. "Stem cell research holds tremendous promise for the development of novel therapies for many serious diseases. However, as clinicians and scientists, we recognize an urgent need to address the problem of unproven stem cell treatments being marketed directly to patients."

Too often rogue clinics around the world exploit patients' hopes by offering unproven stem cell therapies, typical
'/>"/>

SOURCE International Society for Stem Cell Research
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank
3. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
4. Arrow International Files and Mails Definitive Proxy Materials
5. Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software
6. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
7. Viragen International to Reverse Split Its Common Stock
8. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
9. Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
10. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
11. Biosafety and Biosecurity International Conference 2007 to be held in Abu Dhabi from November 12 to 14

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...KJAVIK, Iceland, November 24 /PRNewswire-FirstCall...nnounced the approval of all of its,"first day" mo...t of Delaware,(the "Bankruptcy Court"). deCODE las... Chapter 11 of the United States Bankruptcy Code w...sued by the Bankruptcy Court allow the company to ...
(Date:11/24/2009)...Newswire/ -- Blue Marble Energy Corp. announced to...ment Authority (OPDA) were recently awarded $2 mil...talization Board (CERB) in a private/public partne...chemical biorefinery in Lincoln County, WA. ,...velopment of our biorefinery and bring over 70 gre...
(Date:11/24/2009)...r 24 Shire plc (LSE: SHP...ceutical company, today,announced that it has subm...elaglucerase alfa, the company,s enzyme replacemen... 1 Gaucher disease. This is the third marketing,ap...mitted, with previous,submissions in the United St...
(Date:11/24/2009)...m Connects Customers with Partners Validated to Pr...ek Products , Ottawa, ON ...ing provider of products for biological sample col...unced its new global partner program. The program ...partner community and is designed to help partners...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...ear and fourth quarter 2007 preservation services ...pectively, to approximately $93.7 million for the...TLANTA, Jan. 10 CryoLife, Inc. (NYSE: CRY ),a bi...ompany, announced,today that preservation services...$93.7 million compared to $81.1 million in 2006, a...
...esearchers designing and building new microelectro...est method developed at the National Institute of ...echanical property of such systems: elasticity. Th... films not only for MEMS devices but also for semi... 1727, scientists and engineers have used Youngs m...
...meros Corporation announced today that,it has file... Exchange,Commission relating to the proposed init... All shares of the common stock to be sold in the ...Securities Inc. will be acting as,the sole book-ru...e acting,as the co- lead manager, and Leerink Swan...
Other Biology Technology:CryoLife Announces Record Preservation Services and Product Revenues for 2007 2CryoLife Announces Record Preservation Services and Product Revenues for 2007 3CryoLife Announces Record Preservation Services and Product Revenues for 2007 4NIST develops test method for key micromechanical property 2Omeros Corporation Files Registration Statement for Proposed Initial Public Offering 2
(Date:11/25/2009)... Soil is the linchpin of the environment, where at... that, many students see soil as "just dirt" a pl... educators are challenged with the task of helping...portance of soil in the environment. , A collab...teachers at University of Nebraska-Lincoln, Oregon...
(Date:11/24/2009)...een prescribed by traditional healers in Brazil to...ach pain to fever and flu. , Now for the first ti...able to scientifically prove the pain relieving pr...razilian mint. , Testing this ancient South Ameri...ela Rocha was able to show that when prepared as a...
(Date:11/24/2009)...labby arteries from collapsing have been true life... longer needed -- once the arteries are strengthen...ad no choice but to leave them in place. , Prof....ent of Biomedical Engineering has developed a new ...here they,re needed, then dissolves. , "Our new ...
Breaking Biology News(10 mins):It's not just dirt! 2Got a pain? -- Have a cup of Brazilian mint 2A coating for life 2Eliminate the Blues with Color Therapy 54599 1Eliminate the Blues with Color Therapy 54599 2Eliminate the Blues with Color Therapy 54599 3New nanolaser key to future optical computers and technologies 13581 1New nanolaser key to future optical computers and technologies 13581 2New nanolaser key to future optical computers and technologies 13581 3Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 54596 1Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 54596 2Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 54596 3Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 54596 4
...Foundation, through its Autism Research Initiative...h the Rutgers University Cell and DNA Repository (...r autism studies. The samples will be collected fr...d. , The Simons Simplex Collection, as this proj...r a new and different line of research into the ge...
...September 04, 2007 - The term "biotechnology" elic...ar and hostility. Alan McHughen from the Universit... at large the current state public knowledge of bi...cy and the role of the media. How is coexistence d...agricultural biotech only big companies or also t...
...h showing that dog-walking in bushland significant...support to bans against the practice in sensitive ...uments and debate about the ecological impacts of ...d because experimental evidence has been lacking. ...e dogs as predators and avoid dog-walking areas is...
Other Biology News:Rutgers Genetics receives $7.8 million for autism research 2Rutgers Genetics receives $7.8 million for autism research 3How the public perceives biotech 2A dog in the hand scares birds in the bush 2
Sheep Anti-Human CATHEPSIN G Polyclonal Antibody, Unconjugated from AbD Serotec
Flammable Chemical Cabinets, Justrite Model 25042 from South Coast Enterprises
Mouse Anti-Bovine CD335 Monoclonal Antibody, ALEXA FLUOR 488 Conjugated, Clone AKS1 from AbD Serotec
Sheep Anti-Human Aminopeptidase P1 / XPNPEP1 Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: